跳至主要内容
临床试验/IRCT138807012498N1
IRCT138807012498N1已完成3 期

Combined nonsteroidal anti-inflammatory drug, muscle relaxant, and caffeine versus nonsteroidal anti-inflammatory drug or mucle relaxant monotherapy for acute mechanical low back and/or cervical pain. A double blind, randomized, multicenter, phase III study.

Ache Laboratories0 个研究点目标入组 714 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
714

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
Male

入选标准

  • Inclusion criteria
  • -Male or female subjects, 18 to 65 years of age
  • -Written informed consent
  • -Having acute mechanical lower back and/or cervical pain
  • -VAS score minimum of 50 mm at time of entry into study.
  • Exclusion criteria
  • -Subject is pregnant or lactating woman , or a woman of childbearing potential not using an acceptable method of contraception
  • -Medical history or physical examination results that suggest the pain, symptoms or signs are caused by a serious medical condition (e.g., fever in the last days, diabetes, cancer, rheumatic diseases, cardiac, liver, renal diseases)
  • -History of active peptic ulcer or gastrointestinal (GI) bleeding, history of gastric pain with NSAIDs,
  • -Known allergies, hypersensitivity, or intolerance to any drugs used in the study
  • -Known or suspected history of alcohol or drug abuse
  • -History of epilepsy or recurrent seizures
  • -Creatinine > 1.3 mg/dl

排除标准

  • 未提供

研究者

发起方
Ache Laboratories

相似试验